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Abstracts of Original Contributions: 47th Annual Scientific Session 
The American College of Cardiolegy is pleased to 
announce that nearly 6,000 abstrn¢ts of original con- 
trihutlons were mbmitted to the Program Committee 
of the 47th Annual Scientific S~don. Space and 
time considerations thls year allowed the ~leetion of 
Z,260. 
Each abstract was peer reviewed by a panel of 
graders; chosen al~•lraets are presented in either oral 
or po~ter format. 
The Amedca.n College at" Cardl~!ogy thank~ the 
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I 1001-107]  Functional  Recovery  of  Impaired Lef l  VenlTicular 
Func, fion Follc~in 9 Revascularization: 
Predictive Value ot Dual Energy Single Photon 
Emission Computed Tomography With 
Ruodne-18-Deox~lucose and 
Techne l ium~m-Ses lamlb l  
A_ Hashm'toto, A.J. Ftschman. M. Monm. H.K. G0td. Tsuneh~ro Ya~da 
Ma.ssachusetts General Hospital, Bo~'to,~ MA, USA 
Backgreu~S: The at~t~ty el myocar~a~ perfus~on rmag~ng studies, performed 
at re~, to determine whether ak~net~c myocardtal zone can recover tunCt~on 
post revasculanzat~n is poor. Thus, Ct would be a great advantage to be able 
tO n~t~ably p~ed~ct functional recovery. 
Mett~ds: We investigated the pre~ctab~h'~ of dual ene:'gy SPECT w~th 
Ftuo~ne-tS-deoxyglucose (FOG) and Technet/um-99m-Se~am~b~ (MIBI) un- 
der fastlng cond*t~en for recovery of contractile ciysfunct~on after re~,ascular- 
~zat~o~. dual photon SPECT after srmutt~"teous rn~on of MIB| (20 mCq 
and FDG (10 mCi) was performed in 69 cottsecut~,e pat~en~ (a~. 65 ± 11 
yeats, 50 males, 19 females) with unstable angina (1VD = 13, 2VD = 25, 
3VD = 31), including I t palienta suffenng from acute heart failure 39 patients 
(57%,) expenenced pror myocardial infarCt~0ns and 16 pattenS, (23%) w~th 
history of CABG. 
Results: Normal MIB| uptake was obsert-8~ in 19 patients (27%) (P~0rmal 
group), retatnmty preserved FDG uptake in regions of reduced MfB0 uptake 
were found in 33 (48%) (mismatched group), and absent FDG uptake in 
areas ot reduced MIBI uptake were observed in 17 (25%) (matched group). 
There was no significant difference in pre-revascularizat~on LVEF between 
the mismatched and matched groups (46 ± 14 vs. 45 ± 23%), howover the 
non~at group was significantly greater (66 ¢ 8%, p < 005) than these two 
grOups. Post-revasc~Jlanzation LVEF (152 ± 109 days) significantly increased 
in the mismatch group (54 ± 15%. p -:~ 005), but not in the matched group 
(45 = 19%). The normal group remained unchanged (68 ~: 7%). 
Conclusion: 1. Dual energy SPECT with FOG and MIBI can identity 
postoperative functional recovery in patients with unstable angina. 2. The 
procedure requires only 20 rain. of imaging. 
[ 1001 - 1081 The Range of QCA Velocities for TIMI Grades 2 & 
3 Row 
J. Moynihan. K. Ryan. A. Spareno. M. Kelley. M. Rizzo. S. Marble. 
C.P. Cannon. C. McCabe. M. Gibson• For the TIMt tOA & B Study Group: 
Brigham & Women~ Hospital Boston MA. USA 
The achievement of TIMI Grade 3 Flow afler thrombotysis has been a.~soci- 
ated with improved clinical outcomes• The goal of this study was to determine 
the range of velocities for TIMI Grade 3 Flow b~/measuring the length (cm) of 
the artery in minimally foreshortened views & the time to traverse this length 
thon~nds of abslract participants and the hundreds or 
catego W graders and chairs for their efforts. 
Edwin L, Alderman, MD, FACC 
Co.Chalr 
1998 Annuul Scient~lic Session Program Committee 
Judith L. Swain, MD, FACC 
Co.Choir 
!998 Annual Scient¢'lic Session Program Committee 
|TIM! Frame Count/30 = seconds) to arnve at the QCA vetoclly (cm,~ec), The 
mean (~3A velooty tin' TIMI Grade 3 Flow was 14.7 -~ 8.2 cm/sec (n ~ 487) 
& for TIM! Grade 2 Flow was 5~7 ± 2.4 crrdsec (n ~ 157). There wa~s over a 
4 fok~ range of vetoc~es for b0th TIM! Grades 2 & 3 Row (see below). TIM1 
Grac~e 2 Flow proximal to the stenosis was slightly faster than TIM1 G~ 
3 Row d~stal to the stenos~s (17,0 ± 14.7 cm/sec, n = 175 vs 14,7 ± 9.4 
cm/sec, n = 482, p = 002). 
mTIMI Grade 3 Flow (n~187) 
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QCA Velocity (cm/se¢) 
Conclusion: There is a range at vefoQties that ~: ~titutes TIMI Grade 3 
Flow. Them is substantial overlap in vefoc'Jty bet ;ten TIMI Grades 2 & 3 
Flow. TIMI 2 Row proximal to the lesion is re,tier than TIMI 3 Row distal to 
the. res~on, 
i 1001-10g ] Reproducibility of the Corrected TIM/Fra .me. 
Count in Angiograms of MI Patients Hecetvmg 
Thrombolysls 
T.13 IvanC. TD. Cmwe. EM Balazs, D.L. Debowey. S.G. Ellis. The 
C/eve/anti Chn/c Foundation Cleveland. Ohio. USA 
Background: TIMI fl0w grade is the accepted method for assessing coronary 
flow in MI angiogrems, but is 3ubject(ve. The corrected TIMI frame count 
method was developed to =reprove precision and reproducibility, but few data 
descnbe observer vanability, 
Methods: Using the corrected TIMI frame count method, three indepen- 
dent observers analyzed 60 randomly selected angiograms from a 603 
patient thrombolyhe thai and repeated their analysis six months later. An- 
giograms were excluded for total occlusion (n = 13) and technical inadequa- 
cies (n = 9), such as poor panning. Each observer was blinded to his/her initial 
frame counts and the other observers' counts. Mean frame count averaged 
37.4 ~ 20.0 frames at initial readings and 38.2 ~ 20.8 6 months later. The 
average of the standard deviations among observers was 1.4 (0.0-3.5) at 
initial readings and 1.8 (0.6-4.5) 6 months later. Linear regression analysis 
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of in*,erobaerver variability revealed an average r value of 0.97. The table 
fists Intreobserver variability using paired student's t-tsst. 
Initial Rending 0 month Rending 
Obo Palm Moan differ p value r value mean differ p value r value 
Obl 1.2 1 ,? .:0,0001 0,OR 1.5 <0.001 0.9g 
Oba 1,3 0,1' ,~0,04 0,OO -O,0 <0,175 0,09 
Oba 2.3 -1,0 <0,0t 0.9O -2.1 <0.001 0.gO 
Conclusions: The Inter- and Intmobs6rver variability data demonstrate 
only moderato differences In maaauram6nt feohnlquo over time, averaging 
16as than .~2 frame, The excellent reproducibility results Indicate that TIMI 
frame ~ount la n oultsble method for core laboratory analysis of roperfuslon, 
~ Plt|ml Levels and Plntelot Expression of 
P-~eleotln in Patients With Aoute Myooerdlnl 
Infarotlon After ThrombolyUo Therapy: Indicator 
of 8uoe~esful Rspeffullon? 
P,A, G~rbet, V,L, 8orabmsny, M,R, Oalosandm, D,M, O'Connor, Union 
M~morl~l Hosplf~l, ~/flmom, MD; Cenfo~or, leo,, Malvem R~: O~/m 
Unlmr~l~ Me#/~al Center, Ourrmm, NC, USA 
~,s¢~/ro~n¢l; Administration of antibodies against P,selecfln poor fo raper. 
fusion can reduce infamt size, and improve thrembolysts in antm~l models, 
We defined fha eftsot8 of thrembotyllc therapy on the piatalat expression 
and plasma level8 of P.soloctin following attempted raporfuslon, and corm, 
Isled rheas dots with the clinical outcomes in patients with aoufe myocardial 
Interstice (AMI), 
Metho~ ancl R~ults: Plstelat.pound end soluble P,selectln were men- 
Itomd at praape¢lfled time points In 23 patients, enrolled In the GUSTO.Ill 
trial Failure to repoduso (n ~ 3) and reourmnf Is~homla (n - 2) were observed 
in 5 patients who subsequently undon,~nt emergency angioplsery, Ei,lhteen 
patients ware successfully reperfused, Plasma levels of P.seleotln ~um con- 
slstentty at loser twice higher in AMI patients, irrespective of the success of 
fhrembotytlo therapy, when compared with healthy controls, An Incresse of 
plasma P-sol . in levels was observed af 3 hours after ct~r¢easful threm, 
boty~ls (p ,= 0,002) end wee followed by a decrease to the basut!ne value 
later after mperluslon, In contrast, those patients who failed to rep~,duse. 
expressed fiat patterns of soluble P-selectln levels during the first 24 hours 
after ett~mptsd thrembotysls. At baseline, plstelef P-selecttn was higher in 
the patients, who failed to reperfuse, ee compared to the succassfulty raper- 
fused group (p = 0,03), and to controls (p = 0,01). There were no substantial 
changes Of the platelet P-selectln expression within the AMI groups, how- 
ever, platstet P.solectln was higher in patients with failed repertusion, and 
this difference was significant at 24 hours (p = 0 04), 
Conclusion: Increased pt~tolet P-aetectln, and absence of an early nse 
in its sohible fraction after attempted reperfuslon may serve ae indicators 
Of unsuo~sdul corons~ thrembotyats in patients presenting with acute my- 
ocardial Infarction, 
• Importence of  Non.chest Pain Presentat ion on 
Short Term Outcomes In Acute Myo©ardlal 
Infamtlon 
G. Heumann, K, Oken, R, Pemy. UniversiTy of Fiends Health Science 
Center JacksonWtle. Ft., USA 
Current guidelines for managemem of acute myocardial toleration (AMI) are 
denved from large scale clinical trials utilizing only patients (pts) admitted to 
the hospital from the Emergency Department lED) with chest pain (CP) of 
supected tschemlc origin, The in-hospital outcomes of points diagnosed wuth 
AMI who do not present to the ED with CP are not known, We compared 
in-hospital outcomes of points admitted from the ED with CP with a discharge 
diagnosis of AMI versus non-CP pts with discharge diagnosis of AMI. 
Ft'esu/ts: During a 6 month period. 128 pts had a discharge diagnosis of 
AMI. Ninety.two (72%) were CP pte edmttted from the ED and 36 (28%) 
were non-CP pts. Of non.CP pls. 58% were admitted to a non-cardiology 
service and 44% had non-cardiac admitting diagnoses. Thirty one of 92 CP 
pts (33%) received acute interventional therapy compared to only 1 of 36 
non-CP pts (3%) (p = 0.0001), Life-threatening complications occurred in 28 
CP pts (32%) versl!s t9 non-CP p~, (53%) (p = 3.018). Six CP tots (7%) died 
in-hospital compared to 8 non-CP pts (22%) (p = 0,011), 
Conclusion: Non-CP pts with AMI represent an important but heretofore 
neglected group of in-hospital pts with AMI. Non-CP pts with AMI were 
significantly more Ilkety to have life-threatening complications, were less likely 
to receive acute inten/entional therapy and had higher in-hospital mortality. 
These findings suggest the need for the development of specific guidelines 
for the diagnosis and management of non-CP pts with AML 
1 ] A New Anglographlc Method to Calculate 
t 
001 m 1 1 2 
Coronary Velocity & Its RMetlonshlp to Clinical 
Outcomes After Thrombolyele 
M, Gibson, A, Spamno, K, Ryan, M, Rlzzo, J, Moynlhnn, M. Kelley, 
S, Marble, 'I", Dodge, C,R Cannon, E, Bmunweld, For the TIM1106 
Investigators; Brigham & Women~ Hospital, Boston MA, USA 
The length of ooronaw ndodes tom) was measured In views that mlnlmg, od 
forashodanlng, & the time to travenle that length wee measured using the 
TIMI Frame CounV30 (= seconds) Io erdve at the (]CA velo~ty ((~n/u¢) 
at 90 mln, after thmmbolyale, TIMI 0/1 Flow had 8 velocity of 0 cm/m~, A 
QCA velocity was aaoerfnlnsd In g3,~% of ptl, ('/03/881), Vellxdtlu In the 
preaCheS & absence of clinical events In pts, randomlsed to TNK or d.PA In 
TIMI 10B were ne follows: 
En~po!gt Present Abnet p.wk, o 
Death In Hoop, S,S ~ T,S(n =~ 33) 9,0 ~ 8,t(n,~ 1'a0) 0.00? 
Death 30 Day ?,S ~ 9,1' (n ,, 30) tz,e ~ a,0 (n ,~ ?3t ) o0~ 
Recur. MI In Hoop. 9,1 ~ 6,6 in.  3t) a.8 ~ 8,1 in,= 1'~) NB 
Sh0¢k In Hemp, fi,S ~ e,0(n ~, el) S,9 ~ 8,1 (n = Tt~) 0,0048 
S0 Min, EF .~40% ?,1 :t ?,~ in.  89) 10,(1 ~. ?,3 (n ~ 4~1) 00001 
Oe~aINRoMl~hock 
or ~F ~40% In Heap,, ..... "t,~, ~ 't.3 ~n ~ 113) !g,tl ± 7,4 ~n ,, 4Q9) <0.0~5 
When the analysis was restflofed to open arfenes, the velocity was in, 
versely related to both an EF ,:40% (p = 0,0006) and the ~ ~nt  
(p =, 0,0002), 
Con~u,Won: QCA velocity is an eMImata of velocity which doe8 not nKlUlm 
Instrementafinn of fhe lesion & is related to clinical Outcomes in acute Mi, 
Health Care Systems end Guldel!naa: 
Related Asps©is of A©ute Myocardial 
infarction Therapy 
Sunday, March 29, 1998, 5:00 p,m,-7:00 p.m, 
Georgia Wodd Congress Center, West Exhibit Hall Level 
Presentation Hour: 5:00 p.m.-7:00 p,m, 
I 1 '002'149]  Gender Baaed Inequit ies Among Payer Groups  
In Hospital  Resource Uti l ization for  Acute 
Myocardial  Infamtlon 
J,G. Canto, W.J. Rogers, N.C. Chandre, W.J. French, H.V. Barton, 
PC Frederick, C. Maynard. For the NRMI 2 Investigators: UAB MeDial 
Center, Birmingham, AL, USA 
In order to ascertain the influence of payer statue among men and women on 
hospital resource utilization for myocardial infamUon in the US. data among 
286,260 non.transtorred patients enrolled from June 1994 to January 1997 
in the National Registry of Myocardial Infection 2 were compared among 4 
payer groups, Logistic regression analyses (adjusted for age and race) were 
performed for the 5 categories t listed below; Cox proportional hazard ratio 
Was pedomled for mortality t and was adjusted for age, race, payer, priOr 
cardiac and medical history, cardiac risk factors, vital signs, Killip class. In 
each comparison, men served as the reference greun. 
Adjusted odds ration (95% CI) for hospital resource utilization by gender 
Women vs Men (referent group) 
Medicare Fee-for Sewlce HMO Medcaid 
N 178,455 70,326 27,318 I0,159 
CATH r 0.68(0.67-0,70) 0,88 {0.65=0.91) 0.86(0.8~-0,90) 096{0.79-O.93) 
PTCA t 0.79(0.77-0.81) 0.38(0,85-0.92) 0.84t0.78-0.69 ) 0.85(0.77-0.94) 
CABS t 0.58(0.56-0.60) 0.76(0.72-0.80} 0,70(0,64..0.76) 0.gO(0.79-1,03) 
Acute RT t 0,68 (0,65-.0,71) 0,73 (0,6&-0,79} 0,76 (0,68-0,85) 0,75 (0,63-0,68) 
Consult t 062 (061-0.63) 0.65 (0.62--0.68) 0.68 (0.64-0,?3) 0,75 (0.69-O.81) 
Mortality  1.05 tl,03, 1,08) 1.13 (1.05, 1.21) 1.23 (1.12, 1,36) 1,24 (1.08, 1.42) 
RT = (acute) repedusion therapy in ideal patients who presented within 12 hours of symp- 
toms. with ST elevation or LBBB. and no contraindications to IV thrombolysis; Consult = 
cardiology consult 
Conclusion: Gender based inequities exist in the utilization of h~pital 
resources, which was significantly lower among women (compared to men) 
within each payer group, and may ultimateJy reflect important differences in 
adjusted hospital mortality. 
